|
|
Volumn 37, Issue 1, 2001, Pages 10-19
|
|
Outcome of acute lymphoblastic leukemia in children with AL90 regimen: Impact of response to treatment and sex difference on prognostic factors
|
|
Author keywords
Acute lymphoblastic leukemia; ALL in boys; Anthracycline; Response to treatment; Risk classification
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ASPARAGINASE;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
DEXAMETHASONE;
DOXORUBICIN;
ENOCITABINE;
ETOPOSIDE;
ETOPOSIDE DERIVATIVE;
MERCAPTOPURINE;
METHOTREXATE;
PREDNISOLONE;
VINCRISTINE;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ADOLESCENT;
ARTICLE;
BRAIN HEMORRHAGE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER REGRESSION;
CANCER RISK;
CANCER SURVIVAL;
CHILD;
DRUG MEGADOSE;
FEMALE;
HIGH RISK PATIENT;
HUMAN;
HYPERTENSION ENCEPHALOPATHY;
HYPOFIBRINOGENEMIA;
INAPPROPRIATE VASOPRESSIN SECRETION;
LIVER DYSFUNCTION;
LYMPHOPROLIFERATIVE DISEASE;
MAJOR CLINICAL STUDY;
MALE;
MINIMAL RESIDUAL DISEASE;
PARALYTIC ILEUS;
PRIORITY JOURNAL;
PROGNOSIS;
SEPSIS;
SEX DIFFERENCE;
TREATMENT FAILURE;
TREATMENT OUTCOME;
VIRUS INFECTION;
6-MERCAPTOPURINE;
ADOLESCENT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ASPARAGINASE;
CHILD;
CHILD, PRESCHOOL;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
DEXAMETHASONE;
DISEASE-FREE SURVIVAL;
DRUG ADMINISTRATION SCHEDULE;
ETOPOSIDE;
FEMALE;
HUMANS;
IMMUNOPHENOTYPING;
INFANT;
LEUKEMIA, LYMPHOCYTIC, ACUTE, L1;
MALE;
METHOTREXATE;
MULTIVARIATE ANALYSIS;
PREDNISOLONE;
PROGNOSIS;
RADIOTHERAPY, ADJUVANT;
REMISSION INDUCTION;
RISK;
RISK FACTORS;
SEVERITY OF ILLNESS INDEX;
SEX FACTORS;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
VINCRISTINE;
|
|
EID: 0034960992
PISSN: 00981532
EISSN: None
Source Type: Journal
DOI: 10.1002/mpo.1156 Document Type: Article |
|
Times cited : (18)
|
|
References (36)
|
